Huons begins construction on third plant in Jecheon
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Huons BioPharma broke ground for a 70-billion-won ($54.8 million) biomanufacturing plant in Jecheon, North Chungcheong, Tuesday.
The five-story production plant, measuring 10,000 square meters (2.4 acres), is scheduled to be completed in 2024 and will produce up to 7.2 million vials of Huons’ Hutox botulinum toxin a year.
Huons BioPharma currently operates two manufacturing plants for the Hutox product in Jecheon. With the addition of the third plant, the company will have a total production capacity of 13.68 million vials per year.
Huons BioPharma’s second Hutox production plant was recently granted a quality certification for the European Good Manufacturing Practice standard from German authorities.
BY SHIN HA-NEE [shin.hanee@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- [THINK ENGLISH] 김민재, 바이에른 뮌헨 이적… 5년 계약
- 'Love After Divorce' returns for fourth season with U.S. contestants seeking love in Cancun
- Fifty Fifty's producer admits to lying about college, work history
- U.S. sends message to North — and China — with second sub visit to South
- UNC makes contact with North over U.S. soldier: Report
- And then there were three: Yang and Kwon sign with Celtic
- [WHY] Why is sex still a taboo subject in Korea?
- North invites Chinese delegation as first post-Covid guests to armistice anniversary
- Suicide spotlights abuse of teachers by students and parents
- Christopher Nolan to appear on Korean TV show as guest before 'Oppenheimer' release in Korea